ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy for WM: An International Collaborative Study
By
ASCO 2022 Conference Coverage
FEATURING
Jithma Abeykoon
By
ASCO 2022 Conference Coverage
FEATURING
Jithma Abeykoon
102 views
June 9, 2022
Comments 0
Login to view comments.
Click here to Login
Lymphoma